-
Microcapsules provide targeted chemotherapy drug delivery to cancer cells
europeanpharmaceuticalreview
December 12, 2019
Development of infrared light-sensitive microcapsules could be the future in targeted drug delivery for cancer treatment, says new research.
-
Merck to Acquire ArQule for $2.7B
ContractPharma
December 11, 2019
Diversifies oncology pipeline with expansion into targeted therapies that treat hematological malignancies.
-
Dong-A ST and Beactica Therapeutics Achieve Key Milestone in Their Collaboration to Develop New Cancer Treatments
biopharmadive
December 10, 2019
Dong-A ST Co., Ltd. (170900: Korea SE), a Korean pharmaceutical company...
-
ImCheck raises Series B funds to develop gamma delta therapies
pharmaceutical-technology
December 09, 2019
French biotech firm ImCheck Therapeutics has raised $53m (€48m) in a Series B funding round to develop its gamma delta (γδ) T-cell-based antibodies to treat cancer and autoimmune disorders.
-
BitBiome to analyse gut bacteria related to cancer
biospectrumasia
December 09, 2019
BitBiome, Inc., a start-up company from Waseda University in Japan, and National Cancer Center of Japan have signed a collaborative research agreement on the analysis of gut bacteria related to cancer on November 22nd.
-
Apollo Hospitals' Unique Initiative to Provide Best Treatment Plan for Cancer Patients
En-CPhI.CN
October 23, 2019
Cancer is the second leading cause of death globally and was responsible for over 9.6 million deaths in 2018 alone.
-
China's first self-developed carbon-ion therapy system gets market access
NMPA
October 16, 2019
China's first self-developed carbon-ion therapy system has been approved by the national drug regulator and obtained market access.
-
Datar Cancer Genetics Announces Positive Results With 42.9% Objective Response Rate, and 90.5% Disease Control Rate in Heavily Pre-treated Patients With Ultra-personalised Pan-cancer Treatment Protocol in the RESILIENT Trial
En-CPhI.CN
October 11, 2019
Datar Cancer Genetics, a cancer research company, today announced positive data from the phase II/III RESILIENT trial intended to validate clinical benefit for cancer patients ...
-
Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy
En-CPhI.CN
October 10, 2019
Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer.
-
US researchers develop CAR T cell therapy for cancer
pharmaceutical-technology
September 27, 2019
Researchers at the City of Hope cancer research centre are developing a chimeric antigen receptor (CAR) T-cell therapy for the treatment of relapsed blood cancers.